http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005060322-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c2e31db20685817ff23599cb98ec24f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-45 |
| filingDate | 2003-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1cf5092403a8f5a7d9c2c5f9948934e |
| publicationDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005060322-A |
| titleOfInvention | Autoimmune nephropathy treatment or prevention agent, and recombinant vector therefor |
| abstract | PROBLEM TO BE SOLVED: To provide an autoimmune nephropathy treatment or prevention agent and a recombinant vector therefor, which exhibit excellent therapeutic and preventive effects on autoimmune nephropathy such as systemic lupus erythematosus. By administering Toxoplasma gondii HSP70 protein, an excellent therapeutic and preventive effect is obtained for autoimmune renal disorders such as systemic lupus erythematosus. By administering a recombinant vector that produces HSP70 protein in vivo, an excellent therapeutic and preventive effect against autoimmune renal injury can be obtained. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010035469-A |
| priorityDate | 2003-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.